ChromoGenics appointed Anne-Marie Gullman as interim CFO and Head of Investor Relations as of June 12, 2023. Anne-Marie has broad experience from roles as Finance Manager and CFO and holds a degree in economics from Karlstad University as well as a master's degree in economics from Stockholm University.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 SEK | +5.28% | -5.34% | -8.86% |
02/04 | ChromoGenics AB Receives First Order for North America | CI |
08/03 | ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.86% | 3.88M | |
+19.67% | 15.13B | |
+30.36% | 7.93B | |
+14.62% | 2.57B | |
+18.03% | 1.15B | |
+26.31% | 823M | |
-0.14% | 405M | |
+6.84% | 374M | |
+7.65% | 232M | |
+14.62% | 195M |
- Stock Market
- Equities
- CHRO Stock
- News ChromoGenics AB
- Chromogenics Appoints Anne-Marie Gullman as Interim CFO as of June 12, 2023